ARQT
Arcutis Biotherapeutics, Inc. Common Stock
$27.99
0.47%
+0.13
Notify me if price changes either direction
Buy ARQT stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.5B
Enterprise value
3.4B
Trailing PE
-215.19231062669
Forward PE
24.67066
PEG Ratio
3.9125874659398
Enterprise to EBITDA
630.705
Enterprise to revenue
8.29
Price to book MRQ
18.431114
Price to sales TTM
8.414652
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
415.6M
EBITDA
1.8M
Diluted EPS TTM
-0.02
Total Cash (MRQ)
224.0M
Current ratio (MRQ)
2.684
Operating Cash Flow (TTM)
27.0M
ARQT trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
